Systemic lupus erythematosus flares during pregnancy (Q50974131)

26 March 2018

review article

1 reference

title

Systemic lupus erythematosus flares during pregnancy (English)

1 reference

26 March 2018

systemic lupus erythematosus

1 reference

1 reference

inferred from title

author

Guillermo Ruiz-Irastorza

series ordinal

2

1 reference

26 March 2018

Munther A. Khamashta

series ordinal

1

object named as

M A Khamashta

1 reference

26 March 2018

3

G R Hughes

1 reference

26 March 2018

publication date

1 February 1997

1 reference

26 March 2018

Rheumatic Diseases Clinics of North America

published in

1 reference

26 March 2018

volume

23

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

15-30

1 reference

26 March 2018

Activation of the Complement Pathway: Comparison of Normal Pregnancy, Preeclampsia, and Systemic Lupus Erythematosus During Pregnancy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Effects of immunosuppressive drugs during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Hypothalamic-pituitary mediated modulation of immune function: prolactin as a neuroimmune peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Serological detection of disease activity in SLE

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Assessment of lupus: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Classical complement activation induced by pregnancy: implications for management of connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Pregnancy in lupus nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Pregnancy and its outcome in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Pregnancy outcome following first trimester exposure to chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Urine neopterin: a new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Obstetric outcome in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Pregnancy does not cause systemic lupus erythematosus to worsen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Entry croteria influence conclusions about rates of flare in lupus pregnancy: comment on the article by petri et al

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Does lupus flare during pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

The Outcome of Pregnancy in Women with Lupus Nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Expression and relationships of seven public idiotypes of DNA-binding autoantibodies on monoclonal antibodies and serum immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

The Hopkins Lupus Pregnancy Center: 1987–1991 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Systemic lupus erythematosus: sex hormones in male patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Lupus and pregnancy studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Prolactin: a stimulator of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Neuroendocrine-immune system interactions and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970312-4

7 January 2021

10.1016/S0889-857X(05)70312-4

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018